Cargando…
Systemic Bone Density at Disease Onset Is Associated With Joint Erosion Progression in Early Naive to Treatment Rheumatoid Arthritis: A Prospective 12-Month Follow-Up Open-Label Study
Objectives: Osteoporosis and bone erosions are hallmarks of rheumatoid arthritis (RA) since disease onset is underpinned by the inflammatory burden. In this observational study, we aimed to dissect the putative RA-related parameters and bone-derived biomarkers associated with systemic and focal bone...
Autores principales: | Bruno, Dario, Fedele, Anna Laura, Tolusso, Barbara, Barini, Angelina, Petricca, Luca, Di Mario, Clara, Barini, Antonella, Mirone, Luisa, Ferraccioli, Gianfranco, Alivernini, Stefano, Gremese, Elisa |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7959810/ https://www.ncbi.nlm.nih.gov/pubmed/33732715 http://dx.doi.org/10.3389/fmed.2021.613889 |
Ejemplares similares
-
Peripheral blood CD4(pos)CD25(pos)FoxP3(pos) cells and inflammatory cytokines as biomarkers of response in rheumatoid arthritis patients treated with CTLA4-Ig
por: Elisa, Gremese, et al.
Publicado: (2022) -
Correction: Peripheral blood CD4(pos)CD25(pos)FoxP3(pos) cells and inflammatory cytokines as biomarkers of response in rheumatoid arthritis patients treated with CTLA4-Ig
por: Gremese, Elisa, et al.
Publicado: (2022) -
Chemerin and PEDF Are Metaflammation-Related Biomarkers of Disease Activity and Obesity in Rheumatoid Arthritis
por: Tolusso, Barbara, et al.
Publicado: (2018) -
Differential synovial tissue biomarkers among psoriatic arthritis and rheumatoid factor/anti-citrulline antibody-negative rheumatoid arthritis
por: Alivernini, Stefano, et al.
Publicado: (2019) -
Tapering and discontinuation of TNF-α blockers without disease relapse using ultrasonography as a tool to identify patients with rheumatoid arthritis in clinical and histological remission
por: Alivernini, Stefano, et al.
Publicado: (2016)